Recently, Joincare & Livzon Pharmaceutical Group signed agreements on poverty alleviation of chronic disease patients with two counties, Guangling County of Shanxi Province and Hunyuan County of Shanxi Province. Joincare & Livzon Pharmaceutical Group will provide 1 million yuan worth of medicines for patients with chronic diseases in Guangling County and Hunyuan County in the first year. It is the first project of poverty alleviation of chronic disease patients successfully landed in North China. Previously, Joincare & Livzon Pharmaceutical Group had started the poverty alleviation of chronic disease patients in Chaoyang County, Sichuan Province and Songpan County, Aba Tibetan and Qiang Autonomous Prefecture, Sichuan Province, which had received widespread attention.

“The number of patients with chronic diseases is high and growing year by year. There are too many families become poor due to illness. Joincare focuses on poverty alleviation of chronic disease patients and donate chronic disease drugs to the poor suffering from chronic diseases without compensation to achieve the goal of targeted poverty alleviation.” The person in charge of public interest of Joincare explained the company’s original intention of poverty alleviation of chronic disease patients. On July 15, the State Council issued the Opinions of the State Council on the Implementation of Healthy China Action, focusing on the prevention and control of major diseases such as cardiovascular and cerebrovascular diseases, cancer, chronic respiratory diseases and diabetes as well as infectious diseases and endemic diseases. Joincare’s poverty alleviation of chronic disease patients has accurate goal and effective measures, and is highly compatible with the state’s opinions on the implementation of healthy china action.

At present, Joincare’s first respiratory product “Compound Ipratropium Bromide Solution for Inhalation” has been approved, taking a key first step in building a leading manufacturer of inhalation preparation. In the future, according to the four chronic diseases, i.e. cardiovascular and cerebrovascular diseases, cancer, chronic respiratory diseases and diabetes, highlighted in the Opinions of the State Council on the Implementation of Healthy China Action, Joincare may adjust the Group’s list of poverty alleviation drugs in combination with the company’s drug types and carry out related medical activities such as respiratory examinations, in order to cover more patients with chronic diseases and help the achievement of healthy China.